RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Aspira Pathlab & Diagnostics Liabilities 2024

Aspira Pathlab & Diagnostics Liabilities

45.91 M INR

Aspira Pathlab & Diagnostics Dividend yield

Ticker

540788.BO

ISIN

INE500C01017

In 2024, Aspira Pathlab & Diagnostics's total liabilities amounted to 45.91 M INR, a -14.11% difference from the 53.46 M INR total liabilities in the previous year.

Aspira Pathlab & Diagnostics Aktienanalyse

What does Aspira Pathlab & Diagnostics do?

Aspira Pathlab & Diagnostics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Aspira Pathlab & Diagnostics's Liabilities

Aspira Pathlab & Diagnostics's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Aspira Pathlab & Diagnostics's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Aspira Pathlab & Diagnostics's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Aspira Pathlab & Diagnostics's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Aspira Pathlab & Diagnostics’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Aspira Pathlab & Diagnostics Stock

What is the level of liabilities of Aspira Pathlab & Diagnostics this year?

Aspira Pathlab & Diagnostics has a debt balance of 45.91 M INR this year.

What were the liabilities of Aspira Pathlab & Diagnostics compared to the previous year?

The liabilities of Aspira Pathlab & Diagnostics have increased by -14.11% dropped compared to the previous year.

What are the consequences of high debt for investors of Aspira Pathlab & Diagnostics?

High liabilities can pose a risk for investors of Aspira Pathlab & Diagnostics, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Aspira Pathlab & Diagnostics?

Low liabilities mean that Aspira Pathlab & Diagnostics has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Aspira Pathlab & Diagnostics affect the company?

An increase in liabilities of Aspira Pathlab & Diagnostics can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Aspira Pathlab & Diagnostics affect the company?

A decrease in the liabilities of Aspira Pathlab & Diagnostics can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Aspira Pathlab & Diagnostics?

Some factors that can influence the liabilities of Aspira Pathlab & Diagnostics include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Aspira Pathlab & Diagnostics so important for investors?

The liabilities of Aspira Pathlab & Diagnostics are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Aspira Pathlab & Diagnostics take to modify the liabilities?

To change its liabilities, Aspira Pathlab & Diagnostics can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Aspira Pathlab & Diagnostics pay?

Over the past 12 months, Aspira Pathlab & Diagnostics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Aspira Pathlab & Diagnostics is expected to pay a dividend of 0 INR.

What is the dividend yield of Aspira Pathlab & Diagnostics?

The current dividend yield of Aspira Pathlab & Diagnostics is .

When does Aspira Pathlab & Diagnostics pay dividends?

Aspira Pathlab & Diagnostics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Aspira Pathlab & Diagnostics?

Aspira Pathlab & Diagnostics paid dividends every year for the past 0 years.

What is the dividend of Aspira Pathlab & Diagnostics?

For the upcoming 12 months, dividends amounting to 0 INR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Aspira Pathlab & Diagnostics located?

Aspira Pathlab & Diagnostics is assigned to the '-' sector.

Wann musste ich die Aktien von Aspira Pathlab & Diagnostics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Aspira Pathlab & Diagnostics from 5/23/2024 amounting to 0 INR, you needed to have the stock in your portfolio before the ex-date on 5/23/2024.

When did Aspira Pathlab & Diagnostics pay the last dividend?

The last dividend was paid out on 5/23/2024.

What was the dividend of Aspira Pathlab & Diagnostics in the year 2023?

In the year 2023, Aspira Pathlab & Diagnostics distributed 0 INR as dividends.

In which currency does Aspira Pathlab & Diagnostics pay out the dividend?

The dividends of Aspira Pathlab & Diagnostics are distributed in INR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Aspira Pathlab & Diagnostics

Our stock analysis for Aspira Pathlab & Diagnostics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Aspira Pathlab & Diagnostics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.